Lung India


Year
: 1983  |  Volume : 1  |  Issue : 3  |  Page : 98--101

Comparative Evaluation Of Sustained Action Combination Of Ephedrine, Theophylline And Phenobarbitone And Salbutamol In Chronic Bronchial Asthma


P. G Kamath1, D. R Singh2 
1 
2 

Correspondence Address:
P. G Kamath


Thirty-one asthmatic patients from a general hospital were taken up for the study. Patients were randomly assigned to either TEP-SA one tablet B.I.D. or salbutamol 4 mg T.I.D. After two weeks of therapy the patients were switched over to the second drug. Patients were assessed on 8th, 15th, 22nd and 29th day of treatment. Results showed TEP-SA and salbutamol both significantly reduced the number of attacks and increased PEFR over pretreatment values. Statistical evaluation of difference in respect to all the parameters of assessment between the two drugs was not significant. Both the drugs were equally well tolerated by all the patients.


How to cite this article:
Kamath P, Singh D. Comparative Evaluation Of Sustained Action Combination Of Ephedrine, Theophylline And Phenobarbitone And Salbutamol In Chronic Bronchial Asthma.Lung India 1983;1:98-101


How to cite this URL:
Kamath P, Singh D. Comparative Evaluation Of Sustained Action Combination Of Ephedrine, Theophylline And Phenobarbitone And Salbutamol In Chronic Bronchial Asthma. Lung India [serial online] 1983 [cited 2021 May 15 ];1:98-101
Available from: https://www.lungindia.com/article.asp?issn=0970-2113;year=1983;volume=1;issue=3;spage=98;epage=101;aulast=Kamath;type=0